Ultrasound in Medicine and Biology
Volume 36, Issue 10 , Pages 1561-1567 , October 2010

Liver Metastases: Sulphur Hexafluoride–Enhanced Ultrasonography for Lesion Detection: A Systematic Review

  • Paolo Cabassa

      Affiliations

    • Department of Radiology, University of Brescia, Brescia, Italy
    • Corresponding Author InformationAddress correspondence to: Paolo Cabassa, Department of Radiology, University of Brescia, Piazzale Spedali Civili 1, 25123 Brescia, Italy.
    • ,
  • Shandra Bipat

      Affiliations

    • Department of Radiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    • ,
  • Laura Longaretti

      Affiliations

    • Department of Radiology, University of Brescia, Brescia, Italy
    • ,
  • Mario Morone

      Affiliations

    • Department of Radiology, University of Brescia, Brescia, Italy
    • ,
  • Roberto Maroldi

      Affiliations

    • Department of Radiology, University of Brescia, Brescia, Italy

Received 27 February 2010 ,Revised 11 May 2010 ,Accepted 11 June 2010.

References 

  1. Albrecht T, Hoffmann CW, Schmitz SA, Schettler S, Overberg A, Germer CT, et al. Phase-inversion sonography during the liver-specific late phase of contrast enhancement: Improved detection of liver metastases. AJR Am J Roentgenol. 2001;176:1191–1198
  2. Albrecht T, Blomley MJ, Burns PN, Wilson S, Harvey CJ, Leen E, et al. Improved detection of hepatic metastases with pulse-inversion US during the liver specific phase of SHU 508A: Multicentric study. Radiology. 2003;227:361–370
  3. Albrecht T, Hohmann J, Oldeburg A, Skrok J, Wolf KJ. Detection and characterisation of liver metastases. Eur Radiol. 2004;14(Suppl 8):25–33
  4. Bauditz J, Quinkler M, Beyersdorff D, Wermke W. Improved detection of hepatic metastases of adrenocortical cancer by contrast-enhanced ultrasound. Oncol Rep. 2008;19:1135–1139
  5. Bipat S, van Leeuwen MS, Comans EF, Pijl ME, Bossuyt PM, Zwinderman AH, et al. Colorectal liver metastases: CT, MR imaging, and PET for diagnosis–meta-analysis. Radiology. 2005;237:123–131
  6. Bleuzen A, Huang C, Olar M, Tchuenbou J, Tranquart F. Diagnostic accuracy of contrast-enhanced ultrasound in focal lesions of the liver using cadence contrast pulse sequencing. Ultraschall Med. 2006;27:40–48
  7. Blomley MJ, Albrecht T, Cosgrove DO, Patel N, Jayaram V, Butler-Barnes J, et al. Improved imaging of liver metastases with stimulated acoustic emission in the late phase of enhancement with the US contrast agent SH U 508A: Early experience. Radiology. 1999;210:409–416
  8. Chami L, Lassau N, Malka D, Ducreux M, Bidault S, Roche A, et al. Benefits of contrast-enhanced sonography for the detection of liver lesions: Comparison with histologic findings. AJR Am J Roentgenol. 2008;190:683–690
  9. Charatcharoenwitthaya P, Enders FB, Halling KC, Lindor KD. Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis. Hepatology. 2008;48:1106–1117
  10. Claudon M, Cosgrove D, Albrecht T, Bolondi L, Bosio M, Calliada F, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS)—update 2008. Ultraschall Med. 2008;29:28–44
  11. Cosgrove DO, Bolondi L. Malignant liver disease. In:  Cosgrove D,  Meire H,  Dewbury K editor. Abdominal and general ultrasound. Edinburgh: Churchill Livingstone; 1993;p. 271–293
  12. Cosgrove D. Achieving optimal diagnostic yield through the use of real-time contrast enhanced ultrasonography. Eur Radiol. 2007;17(Suppl 6):F71–F72
  13. Dietrich CF, Kratzer W, Strobe D, Danse E, Fessl R, Bunk A, et al. Assessment of metastatic liver disease in patients with primary extrahepatic tumors by contrast-enhanced sonography versus CT and MRI. World J Gastroenterol. 2006;21(12):1699–1705
  14. Glover C, Douse P, Kane P, Karani J, Meire H, Mohammadtaghi S, et al. Accuracy of investigations for asymptomatic colorectal liver metastases. Dis Colon Rectum. 2002;45:476–484
  15. Hoeffel C, Job L, Ladam-Marcus V, Vitry F, Cadiot G, Marcus C. Detection of hepatic metastases from carcinoid tumor: Prospective evaluation of contrast-enhanced ultrasonography. Dig Dis Sci. 2009;54:2040–2046
  16. Hohmann J, Albrecht T, Oldenburg A, Skrok J, Wolf KJ. Liver metastases in cancer: Detection with contrast-enhanced ultrasonography. Abdom Imaging. 2004;29:669–681
  17. Janica JR, Lebkowska U, Ustymowicz A, Augustynowicz A, Kamocki Z, Werel D, et al. Contrast-enhanced ultrasonography in diagnosing liver metastases. Med Sci Monit. 2007;13(Suppl 1):111–115
  18. Kim YK, Ko SW, Hwang SB, Kim CS, Yu HC. Detection and characterization of liver metastases: 16-slice multidetector computed tomography versus superparamagnetic iron oxide-enhanced magnetic resonance imaging. Eur Radiol. 2006;16:1337–1345
  19. Kinkel K, Lu Y, Both M, Warren RS, Thoeni RF. Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): A meta-analysis. Radiology. 2002;224:748–756
  20. Konopke R, Kersting S, Saeger HD, Bunk A. Detection of liver lesions by contrast-enhanced ultrasound—comparison to intraoperative findings. Ultraschall Med. 2005;26:107–113
  21. Konopke R, Kersting S, Bergert H, Bloomenthal A, Gastmeier J, Saeger HD, et al. Contrast-enhanced ultrasonography to detect liver metastases: A prospective trial to compare transcutaneous unenhanced and contrast-enhanced ultrasonography in patients undergoing laparotomy. Int J Colorectal Dis. 2007;22:201–207
  22. Konopke R, Bunk A, Kersting S. The role of contrast-enhanced ultrasound for focal liver lesion detection: an overview. Ultrasound Med Biol. 2007;33:1515–1526
  23. Larsen LP, Rosenkilde M, Christensen H, Bang N, Bolvig L, Christiansen T, et al. The value of contrast enhanced ultrasonography in detection of liver metastases from colorectal cancer: A prospective double-blinded study. Eur J Radiol. 2007;62:302–307
  24. Larsen LP, Rosenkilde M, Christensen H, Bang N, Bolvig L, Christiansen T, et al. Can contrast enhanced ultrasonography replace multidetector-computed tomography in the detection of liver metastases from colorectal cancer?. Eur J Radiol. 2009;69:308–313
  25. Leen E, Moug SJ, Horgan P. Potential impact and utilization of ultrasound contrast media. Eur Radiol. 2004;14(Suppl 8):16–24
  26. Lencioni R, Cioni D, Crocetti L, Donati F, Franchini C, Giusti S, et al. Ultrasound imaging of focal liver lesions with a second-generation contrast agent. Acad Radiol. 2002;9(Suppl 2):S371–S374
  27. Lencioni R, Della Pinna C, Crocetti L, Bozzi E, Cioni D. Clinical management of focal liver lesions: The key role of real time contrast-enhanced US. Eur Radiol. 2007;17(Suppl 6):F73–F79
  28. Nicolau C, Catalá V, Brú C. Characterization of focal liver lesions with contrast-enhanced ultrasound. Eur Radiol. 2003;13:N70–N78
  29. Nicolau C, Brú C. Focal liver lesions: Evaluation with contrast-enhanced ultrasonography. Abdom Imaging. 2004;29:348–359
  30. Oldenburg A, Hohmann J, Foert E, Skrok J, Hoffmann CW, Frericks B, et al. Detection of hepatic metastases with low MI real time contrast enhanced sonography and SonoVue. Ultraschall Med. 2005;26:277–284
  31. Piscaglia F, Corradi F, Mancini M, Giangregorio F, Tamberi S, Ugolini G, et al. Real time contrast enhanced ultrasonography in detection of liver metastases from gastrointestinal cancer. BMC Cancer. 2007;3(7):171
  32. Quaia E, D'Onofrio M, Palumbo A, Rossi S, Bruni S, Cova M. Comparison of contrast-enhanced ultrasonography versus baseline ultrasound and contrast-enhanced computed tomography in metastatic disease of the liver: Diagnostic performance and confidence. Eur Radiol. 2006;16:1599–1609
  33. Schneider F, Chapuis L, Gillet M, Leyvraz S, Schnyder P, Meuli R. Detection of malignant focal hepatic lesions. Comparison of ultrasonography, computerized tomography during arterial portography, delayed computerized tomography and magnetic resonance imaging. Gastroenterol Clin Biol. 1999;23:105–113
  34. Solbiati L, Tonolini M, Cova L, Goldberg SN. The role of contrast-enhanced ultrasound in the detection of focal liver lesions. Eur Radiol. 2001;11(Suppl 3):E15–E26
  35. Teefey SA, Hildeboldt CC, Dehdashti F, Siegel BA, Peters MG, Heiken JP, et al. Detection of primary hepatic malignancy in liver transplant candidates: Prospective comparison of CT, MR imaging, US, and PET. Radiology. 2003;226:533–542
  36. Whiting P, Rutjes AW, Reitsma JB, Bossuyte PM. Kleijnen The develompment of QUADAS: A tool for the quality assessment of studies of diagnostics accuracy included in systematic reviews. BMC Med Res Methodol. 2003 Nov 10;3:25
  37. Whiting PF, Weswood ME, Rutjes AW, Reitsma JB, Bossuyt PN, Kleijnen J. Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC Med Res Methodol. 2006 Mar 6;6:9
  38. Yarmenitis SD, Karantanas A, Bakantaki A, Papantoniou Y, Gourtsoyiannis N. Detection of colorectal cancer hepatic metastases with contrast-enhanced ultrasound: Comparison with conventional B-mode ultrasound. Dig Dis. 2007;25:86–93
  39. Zech CJ, Herrmann KA, Reiser MF, Schoenberg SO. MR imaging in patients with suspected liver metastases: Value of liver-specific contrast agent Gd-EOB-DTPA. Magn Reson Med Sci. 2007;6:43–52

PII: S0301-5629(10)00295-4

doi: 10.1016/j.ultrasmedbio.2010.06.004

Ultrasound in Medicine and Biology
Volume 36, Issue 10 , Pages 1561-1567 , October 2010

Article Tools

* Image Usage & Resolution